Allergy Therapeutics plc (AGY.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 04:28PM GMT
| Previous close | 13.50 |
| Open | 0.00 |
| Bid | 12.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 54,769 |
| Market cap | 95.314M |
| Beta (5Y monthly) | 1.23 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.80 |
| Earnings date | 29 Sept 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 61.67 |
- Simply Wall St.
Allergy Therapeutics' (LON:AGY) investors will be pleased with their favorable 55% return over the last three years
Allergy Therapeutics plc ( LON:AGY ) shareholders might be concerned after seeing the share price drop 25% in the last...
- Simply Wall St.
Are Institutions Heavily Invested In Allergy Therapeutics plc's (LON:AGY) Shares?
The big shareholder groups in Allergy Therapeutics plc ( LON:AGY ) have power over the company. Institutions often own...
- GlobeNewswire
Interim Results for the six months ended 31 December 2021
Allergy Therapeutics plc(“Allergy Therapeutics” or the “Company” or the “Group”) Interim Results for the six months ended 31 December 2021 ~ US readiness plan underway including two pivotal trials Portfolio focused on high value growth products to enhance future profitabilityGround-breaking Phase I trial of peanut allergy vaccine on track to commence in 2022 following recent FDA clearance of IND application with data expected sooner than previously anticipatedPivotal Phase III trial of short-cou
© 2022 Yahoo. All rights reserved.
